Oxford launches race for COVID-19 vaccine in over 1,000 volunteers
NCT ID NCT04324606
Summary
This early-stage study tested the safety and ability of the Oxford/AstraZeneca COVID-19 vaccine to prevent infection. It involved 1077 healthy UK adults aged 18-55 who received the vaccine as a shot in the arm. Researchers monitored participants for about a year to check for side effects and see if the vaccine reduced COVID-19 cases and severe illness.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CCVTM, University of Oxford, Churchill Hospital
Oxford, OX3 7LE, United Kingdom
-
Imperial College Healthcare NHS Trust
London, W2 1NY, United Kingdom
-
John Radcliffe Hospital
Oxford, OX3 9DU, United Kingdom
-
St Georges University Hospital NHS Foundation Trust
London, SW17 0QT, United Kingdom
-
University Hospital Southampton NHS Foundation Trust
Southampton, Hampshire, SO16 6YD, United Kingdom
-
University Hospitals Bristol and Weston NHS Foundation Trust
Bristol, BS1 3NU, United Kingdom